GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Market Cap

Benevolent AI (XAMS:BAI) Market Cap : €65.70 Mil (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Benevolent AI's share price for the quarter that ended in Dec. 2023 was €1.08. Benevolent AI's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 124.44 Mil. Therefore, Benevolent AI's market cap for the quarter that ended in Dec. 2023 was €134.40 Mil.

Benevolent AI's quarterly market cap declined from Dec. 2022 (€419.96 Mil) to Jun. 2023 (€161.99 Mil) and declined from Jun. 2023 (€161.99 Mil) to Dec. 2023 (€134.40 Mil).

Benevolent AI's annual market cap increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€419.96 Mil) but then declined from Dec. 2022 (€419.96 Mil) to Dec. 2023 (€134.40 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Benevolent AI's Enterprise Value for Today is €28.47 Mil.


Benevolent AI Market Cap Historical Data

The historical data trend for Benevolent AI's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Market Cap Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - - - 419.96 134.40

Benevolent AI Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only - 959.91 419.96 161.99 134.40

Competitive Comparison of Benevolent AI's Market Cap

For the Biotechnology subindustry, Benevolent AI's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benevolent AI's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Market Cap distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Market Cap falls into.



Benevolent AI Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Benevolent AI's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€1.08*124.44
=€134.40

Benevolent AI's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€1.08*124.44
=€134.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benevolent AI  (XAMS:BAI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Benevolent AI Market Cap Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI (XAMS:BAI) Business Description

Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI (XAMS:BAI) Headlines

No Headlines